featured
Renoprotective Effects of Empagliflozin Plus Liraglutide vs Roux-en-Y Gastric Bypass in Early-Stage Diabetic Kidney Disease
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Diabetes Care
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Renoprotective Effects of the Combination of Empagliflozin and Liraglutide Compared With Roux-en-Y Gastric Bypass in Early-Stage Diabetic Kidney Disease: A Post Hoc Analysis of the Microvascular Outcomes after Metabolic Surgery (MOMS) Randomized Controlled Clinical Trial
Diabetes Care 2021 Aug 06;[EPub Ahead of Print], RV Cohen, TBZ Petry, AD Miras, CM Aboud, B Johnson, TM Dos Santos, CW le RouxFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.